BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7826382)

  • 1. Specific labeling of isoprenylated proteins: application to study inhibitors of the post-translational farnesylation and geranylgeranylation.
    Danesi R; McLellan CA; Myers CE
    Biochem Biophys Res Commun; 1995 Jan; 206(2):637-43. PubMed ID: 7826382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of isoprenyl modified proteins metabolically labeled with [3H]farnesyl- and [3H]geranylgeranyl-pyrophosphate.
    Gromov PS; Madsen P; Celis JE
    Electrophoresis; 1996 Nov; 17(11):1728-33. PubMed ID: 8982605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
    Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
    Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):99-110. PubMed ID: 9221829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
    Graham TE; Pfeiffer JR; Lee RJ; Kusewitt DF; Martinez AM; Foutz T; Wilson BS; Oliver JM
    J Immunol; 1998 Dec; 161(12):6733-44. PubMed ID: 9862703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geranylgeranyl diphosphate-based inhibitors of post-translational geranylgeranylation of cellular proteins.
    Macchia M; Jannitti N; Gervasi G; Danesi R
    J Med Chem; 1996 Mar; 39(7):1352-6. PubMed ID: 8691464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geranylgeranylated proteins are involved in the regulation of myeloma cell growth.
    van de Donk NW; Lokhorst HM; Nijhuis EH; Kamphuis MM; Bloem AC
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):429-39. PubMed ID: 15701825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein prenylation: key to ras function and cancer intervention?
    Khosravi-Far R; Cox AD; Kato K; Der CJ
    Cell Growth Differ; 1992 Jul; 3(7):461-9. PubMed ID: 1419908
    [No Abstract]   [Full Text] [Related]  

  • 9. Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase.
    Wiemer AJ; Tong H; Swanson KM; Hohl RJ
    Biochem Biophys Res Commun; 2007 Feb; 353(4):921-5. PubMed ID: 17208200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoaffinity labeling of yeast farnesyl protein transferase and enzymatic synthesis of a Ras protein incorporating a photoactive isoprenoid.
    Edelstein RL; Distefano MD
    Biochem Biophys Res Commun; 1997 Jun; 235(2):377-82. PubMed ID: 9199201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins suppress THP-1 cell migration and secretion of matrix metalloproteinase 9 by inhibiting geranylgeranylation.
    Wong B; Lumma WC; Smith AM; Sisko JT; Wright SD; Cai TQ
    J Leukoc Biol; 2001 Jun; 69(6):959-62. PubMed ID: 11404382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesylation of p21 Ras proteins in Xenopus oocytes.
    Zhao J; Kung HF; Manne V
    Cell Mol Biol Res; 1994; 40(4):313-21. PubMed ID: 7866432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel (taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells.
    Danesi R; Figg WD; Reed E; Myers CE
    Mol Pharmacol; 1995 Jun; 47(6):1106-11. PubMed ID: 7603448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geranylgeranyl as well as farnesyl moiety is transferred to Ras p21 overproduced in adrenocortical cells transformed by c-Ha-rasEJ oncogene.
    Osman H; Mazet JL; Maume G; Maume BF
    Biochem Biophys Res Commun; 1997 Feb; 231(3):789-92. PubMed ID: 9070894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cells.
    Crick DC; Andres DA; Danesi R; Macchia M; Waechter CJ
    J Neurochem; 1998 Jun; 70(6):2397-405. PubMed ID: 9603204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesyl and geranylgeranyl transferase inhibitors induce G1 arrest by targeting the proteasome.
    Efuet ET; Keyomarsi K
    Cancer Res; 2006 Jan; 66(2):1040-51. PubMed ID: 16424040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel isoprenoid modified proteins in Halobacteria.
    Sagami H; Kikuchi A; Ogura K; Fushihara K; Nishino T
    Biochem Biophys Res Commun; 1994 Sep; 203(2):972-8. PubMed ID: 8093082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farnesol is utilized for protein isoprenylation and the biosynthesis of cholesterol in mammalian cells.
    Crick DC; Andres DA; Waechter CJ
    Biochem Biophys Res Commun; 1995 Jun; 211(2):590-9. PubMed ID: 7794274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein geranylgeranylation is critical for the regulation of survival and proliferation of lymphoma tumor cells.
    van de Donk NW; Schotte D; Kamphuis MM; van Marion AM; van Kessel B; Bloem AC; Lokhorst HM
    Clin Cancer Res; 2003 Nov; 9(15):5735-48. PubMed ID: 14654559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells.
    Agarwal B; Bhendwal S; Halmos B; Moss SF; Ramey WG; Holt PR
    Clin Cancer Res; 1999 Aug; 5(8):2223-9. PubMed ID: 10473109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.